New cancer biotech emerges from Stanford research, with help of Nobel laureate Carolyn Bertozzi
A new solid tumor biotech based on research out of Stanford University is targeting the red-hot fields of cancer immunotherapy and antibody-drug conjugates. TwoStep Therapeutics unveiled itself on...
endpoints.news